Filed: 5/15/2025ACC: 0000908834-25-000177
📋 What this filing means
FARALLON CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 135 equity positions with a total reported market value of $17.94B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
135
Positions
$17.94B
Total AUM (reported)
245.70M
Total Shares
Allocation by class
COM$12.81B71.4%
TR UNIT$1.85B10.3%
CL A$886.15M4.9%
ISHARES BIOTECH$460.44M2.6%
COM CL A$429.77M2.4%
SHS CL A$378.34M2.1%
SHS BEN INT$271.21M1.5%
Portfolio Concentration
Top 3$3.54B19.7%
4–10$4.25B23.7%
11–25$6.18B34.4%
Rest$3.97B22.2%
Top 3 weight
19.7%
Top 10 weight
43.4%
Voting Authority Distribution
Total shares with voting rights: 245.70M
Sole
Full voting authority
245.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other135
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings135
Rows:
SPDR S&P 500 ETF TR
OTRShares3.30M
TypeSH
Market value$1.85B
10.29%
Sole
3.30M
Shared
0.00
None
0.00
MICROSOFT CORP
OTRShares2.29M
TypeSH
Market value$858.08M
4.78%
Sole
2.29M
Shared
0.00
None
0.00
EXELIXIS INC
OTRShares22.53M
TypeSH
Market value$831.94M
4.64%
Sole
22.53M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
OTRShares1.50M
TypeSH
Market value$784.53M
4.37%
Sole
1.50M
Shared
0.00
None
0.00
NATERA INC
OTRShares4.55M
TypeSH
Market value$643.11M
3.59%
Sole
4.55M
Shared
0.00
None
0.00
IQVIA HLDGS INC
OTRShares3.41M
TypeSH
Market value$601.51M
3.35%
Sole
3.41M
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
OTRShares6.02M
TypeSH
Market value$587.87M
3.28%
Sole
6.02M
Shared
0.00
None
0.00
ARAMARK
OTRShares16.24M
TypeSH
Market value$560.67M
3.13%
Sole
16.24M
Shared
0.00
None
0.00
DISNEY WALT CO
OTRShares5.50M
TypeSH
Market value$542.48M
3.02%
Sole
5.50M
Shared
0.00
None
0.00
SALESFORCE INC
OTRShares1.97M
TypeSH
Market value$527.89M
2.94%
Sole
1.97M
Shared
0.00
None
0.00
AUTODESK INC
OTRShares2M
TypeSH
Market value$522.92M
2.92%
Sole
2M
Shared
0.00
None
0.00
INTUIT
OTRShares840.26K
TypeSH
Market value$515.91M
2.88%
Sole
840.26K
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
OTRShares1.04M
TypeSH
Market value$515.44M
2.87%
Sole
1.04M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
OTRShares13.53M
TypeSH
Market value$478.59M
2.67%
Sole
13.53M
Shared
0.00
None
0.00
ISHARES TR
OTRShares3.60M
TypeSH
Market value$460.44M
2.57%
Sole
3.60M
Shared
0.00
None
0.00
TRANSUNION
OTRShares5.41M
TypeSH
Market value$449.24M
2.50%
Sole
5.41M
Shared
0.00
None
0.00
NEW YORK TIMES CO
OTRShares8.93M
TypeSH
Market value$443.03M
2.47%
Sole
8.93M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
OTRShares3.06M
TypeSH
Market value$403.02M
2.25%
Sole
3.06M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
OTRShares3.76M
TypeSH
Market value$379.59M
2.12%
Sole
3.76M
Shared
0.00
None
0.00
AON PLC
OTRShares1.36M
TypeSH
Market value$378.34M
2.11%
Sole
1.36M
Shared
0.00
None
0.00
MCKESSON CORP
OTRShares552.50K
TypeSH
Market value$371.83M
2.07%
Sole
552.50K
Shared
0.00
None
0.00
NASDAQ INC
OTRShares4.46M
TypeSH
Market value$338.36M
1.89%
Sole
4.46M
Shared
0.00
None
0.00
CBRE GROUP INC
OTRShares2.50M
TypeSH
Market value$326.39M
1.82%
Sole
2.50M
Shared
0.00
None
0.00
SCHWAB CHARLES CORP
OTRShares3.83M
TypeSH
Market value$300.04M
1.67%
Sole
3.83M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
OTRShares6.11M
TypeSH
Market value$295.33M
1.65%
Sole
6.11M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TROTR | TR UNIT | 3.30M | SH | $1.85B 10.29% | 3.30M | 0.00 | 0.00 |
MICROSOFT CORPOTR | COM | 2.29M | SH | $858.08M 4.78% | 2.29M | 0.00 | 0.00 |
EXELIXIS INCOTR | COM | 22.53M | SH | $831.94M 4.64% | 22.53M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCOTR | COM | 1.50M | SH | $784.53M 4.37% | 1.50M | 0.00 | 0.00 |
NATERA INCOTR | COM | 4.55M | SH | $643.11M 3.59% | 4.55M | 0.00 | 0.00 |
IQVIA HLDGS INCOTR | COM | 3.41M | SH | $601.51M 3.35% | 3.41M | 0.00 | 0.00 |
LANTHEUS HLDGS INCOTR | COM | 6.02M | SH | $587.87M 3.28% | 6.02M | 0.00 | 0.00 |
ARAMARKOTR | COM | 16.24M | SH | $560.67M 3.13% | 16.24M | 0.00 | 0.00 |
DISNEY WALT COOTR | COM | 5.50M | SH | $542.48M 3.02% | 5.50M | 0.00 | 0.00 |
SALESFORCE INCOTR | COM | 1.97M | SH | $527.89M 2.94% | 1.97M | 0.00 | 0.00 |
AUTODESK INCOTR | COM | 2M | SH | $522.92M 2.92% | 2M | 0.00 | 0.00 |
INTUITOTR | COM | 840.26K | SH | $515.91M 2.88% | 840.26K | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCOTR | COM | 1.04M | SH | $515.44M 2.87% | 1.04M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCOTR | COM | 13.53M | SH | $478.59M 2.67% | 13.53M | 0.00 | 0.00 |
ISHARES TROTR | ISHARES BIOTECH | 3.60M | SH | $460.44M 2.57% | 3.60M | 0.00 | 0.00 |
TRANSUNIONOTR | COM | 5.41M | SH | $449.24M 2.50% | 5.41M | 0.00 | 0.00 |
NEW YORK TIMES COOTR | CL A | 8.93M | SH | $443.03M 2.47% | 8.93M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCOTR | COM | 3.06M | SH | $403.02M 2.25% | 3.06M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPOTR | COM | 3.76M | SH | $379.59M 2.12% | 3.76M | 0.00 | 0.00 |
AON PLCOTR | SHS CL A | 1.36M | SH | $378.34M 2.11% | 1.36M | 0.00 | 0.00 |
MCKESSON CORPOTR | COM | 552.50K | SH | $371.83M 2.07% | 552.50K | 0.00 | 0.00 |
NASDAQ INCOTR | COM | 4.46M | SH | $338.36M 1.89% | 4.46M | 0.00 | 0.00 |
CBRE GROUP INCOTR | CL A | 2.50M | SH | $326.39M 1.82% | 2.50M | 0.00 | 0.00 |
SCHWAB CHARLES CORPOTR | COM | 3.83M | SH | $300.04M 1.67% | 3.83M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCOTR | COM | 6.11M | SH | $295.33M 1.65% | 6.11M | 0.00 | 0.00 |
Page 1 of 6
…